Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/IINK/T-cell lymphomaopen access
- Authors
- Kwong, Yok-Lam; Kim, S. J.; Tse, E.; Oh, S. Y.; Kwak, J. Y.; Eom, H. S.; Do, Y. R.; Mun, Y. C.; Lee, S. R.; Shin, H. J.; Suh, C.; Chuang, S. S.; Lee, Y. S.; Lim, S. T.; Izutsu, K.; Suzuki, R.; Relander, T.; d'Amore, F.; Schmitz, N.; Jaccard, A.; Kim, Won Seog
- Issue Date
- Jan-2018
- Publisher
- Oxford University Press
- Keywords
- stage I/IINK/T-cell lymphomas; concurrent chemoradiotherapy; sequential chemotherapy and radiotherapy
- Citation
- Annals of Oncology, v.29, no.1, pp 256 - 263
- Pages
- 8
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 29
- Number
- 1
- Start Page
- 256
- End Page
- 263
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/29073
- DOI
- 10.1093/annonc/mdx684
- ISSN
- 0923-7534
1569-8041
- Abstract
- Background
In stage I/II natural killer (NK)/T-cell lymphoma, concurrent chemoradiotherapy (CCRT) had previously been shown to result in superior outcome compared with anthracycline-containing regimens, which have since been considered ineffective. The role of CCRT in comparison with approaches employing nonanthracycline-containing chemotherapy (CT) and sequential radiotherapy (RT) in such patients remains to be defined.
Patients and methods
Three hundred and three untreated patients (207 men, 96 women; median age: 51, 18–86 years) with stage I/II NK/T-cell lymphoma who had received nonanthracycline-containing regimens were collected from an international consortium and retrospectively analyzed. Treatment included single modality (CT and RT), sequential modalities (CT + RT; RT + CT) and concurrent modalities (CCRT; CCRT + CT). The impact of clinicopathologic parameters and types of treatment on complete response (CR) rate, progression-free-survival (PFS) and overall-survival (OS) was evaluated.
Results
For CR, stage (P = 0.027), prognostic index for NK/T-cell lymphoma (PINK) (P = 0.026) and types of initial treatment (P = 0.011) were significant prognostic factors on multivariate analysis. On Cox regression analysis, ECOG performance score (P = 0.021) and PINK-EBV DNA (PINK-E) (P = 0.002) significantly impacted on PFS; whereas ECOG performance score (P = 0.008) and stage (P < 0.001) significantly impacted on OS. For comparing CCRT ± CT and sequential CT + RT, CCRT ± CT patients (n = 190) were similar to sequential CT + RT patients (n = 54) in all evaluated clinicopathologic parameters except two significantly superior features (higher proportion of undetectable circulating EBV DNA on diagnosis and lower PINK-E scores). Despite more favorable pre-treatment characteristics, CCRT ± CT patients had CR rate, PFS and OS comparable with sequential CT + RT patients on multivariate and Cox regression analyses.
Conclusions
In stage I/II NK/T-cell lymphomas, when effective chemotherapeutic regimens were used, CCRT and sequential CT + RT gave similar outcome.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Medical Oncology and Hematology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.